Figure 1 | Scientific Reports

Figure 1

From: Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy

Figure 1

Organoid formulation and general experimental layout. (a) Schematic for the construction of the organoids. This equates to 300,000 immune cells and 100,000 cancer cells in each organoid (b) Control group that is not treated with bacterial metabolites or ICB for the 5-day course of the experimental trial. (c–e) Organoids are treated with ICB alone (c), bacterial metabolites alone (d), and a combination of ICB and metabolites (e).

Back to article page